Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2018 Filed Feb 20, 2018 21:01 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 225,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001715 · section16.xml · derivative · entry 2 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: The options vest 25% on the date of grant (2/16/2018), and 25% on the first, second and third anniversaries of the date of grant, subject to Optionee's continued service through such date. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:04 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001719 · section16.xml · derivative · entry 4 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:04 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001719 · section16.xml · derivative · entry 3 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:04 UTC |
Kaplan MyronDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001719 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: These options were granted on 2/16/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC |
Dillione JanetDirector
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001717 · section16.xml · derivative · entry 4 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC |
Dillione JanetDirector
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001717 · section16.xml · derivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC |
Dillione JanetDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001717 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC |
Gelbfish Gary A.Director
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001718 · section16.xml · derivative · entry 4 Gelbfish Gary A. · CIK 0001488011 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vests in full on the first anniversary of the date of grant, subject to continued service on the board. F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vests in full on the first anniversary of the date of grant, subject to continued service on the board. F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vests in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC |
Gelbfish Gary A.Director
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001718 · section16.xml · derivative · entry 3 Gelbfish Gary A. · CIK 0001488011 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F2 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:05 UTC |
Lefkowitz Steven WDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001721 · section16.xml · derivative · entry 6 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F4 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F4 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F4 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:05 UTC |
Lefkowitz Steven WDirector
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001721 · section16.xml · derivative · entry 5 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stick · 10,000 shares Expires not disclosed F4 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F4 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F4 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:05 UTC |
Lefkowitz Steven WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001721 · section16.xml · derivative · entry 4 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F3 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:04 UTC |
Khan MehmoodDirector
|
GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001720 · section16.xml · derivative · entry 4 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:04 UTC |
Khan MehmoodDirector
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001720 · section16.xml · derivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:04 UTC |
Khan MehmoodDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001720 · section16.xml · derivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:02 UTC |
Cook Robert W.Chief Financial Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 45,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001716 · section16.xml · derivative · entry 2 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: The options vest 25% on the date of grant (2/16/2018), and 25% on the first, second and third anniversaries of the date of grant, subject to Optionee's continued service through such date. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:00 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 45,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001714 · section16.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: The options vest 25% on the date of grant (2/16/2018), and 25% on the first, second and third anniversaries of the date of grant, subject to Optionee's continued service through such date. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:23 UTC Amendment |
Kaplan MyronDirector
|
GrantStock Option (Right to Buy Common STock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-013417 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F2 · derivative.exercise_date: These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:23 UTC Amendment |
Kaplan MyronDirector
|
GrantRestricted Stock Units | 22,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013417 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,166 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. The restricted stock units vest monthly and will vest in full on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:10 UTC Amendment |
Dillione JanetDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-013409 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F2 · derivative.exercise_date: These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:10 UTC Amendment |
Dillione JanetDirector
|
GrantCommon Stock | 14,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013409 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,052 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:19 UTC Amendment |
Gelbfish Gary A.Director
|
GrantCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013415 · section16.xml · nonDerivative · entry 1 Gelbfish Gary A. · CIK 0001488011 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,111,121 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 21:17 UTC Amendment |
Khan MehmoodDirector
|
GrantCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013413 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,583 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. These restricted stock units will vest monthly with vesting in full on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 21:08 UTC Amendment |
Lefkowitz Steven WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-013408 · section16.xml · derivative · entry 4 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F4 · derivative.exercise_date: These options were granted on 2/16/2018. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 21:08 UTC Amendment |
Lefkowitz Steven WDirector
|
GrantCommon Stock, $0.001 par value per share | 16,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013408 · section16.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,379 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. F2 · ownership.direct: Includes 24,963 shares held by the reporting person for the benefit of his minor son. Read SEC document |
| February 14, 2018 Filed Feb 15, 2018 16:02 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 13,392 | $0.56 Strike: $0.00 | $7,499.52 |
DisclosureSEC source: 0001654954-18-001607 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 Underlying: Common Stock · 13,392 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| December 31, 2017 Filed Mar 22, 2018 20:02 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 18,028 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002933 · section16.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,029 Underlying: Common Stock · 18,028 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested 50% on December 31, 2017 and 50% will vest on December 31, 2018, subject to continued employment. Read SEC document |
| December 31, 2017 Filed Mar 22, 2018 20:02 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
Exercise / conversionCommon Stock | 18,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002933 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vested 50% on December 31, 2017 and 50% will vest on December 31, 2018, subject to continued employment. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:06 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 104,166 | $0.48 | $49,999.68 |
DisclosureSEC source: 0001654954-17-011648 · section16.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,373 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 16:29 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 104,166 | $0.48 | $49,999.68 |
DisclosureSEC source: 0001654954-17-011663 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,166 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 16:12 UTC |
Gelbfish Gary A.Director
|
PurchaseCommon Stock, $0.001 par value per share | 52,083 | $0.48 | $24,999.84 |
DisclosureSEC source: 0001654954-17-011653 · section16.xml · nonDerivative · entry 1 Gelbfish Gary A. · CIK 0001488011 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,101,121 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 16:13 UTC |
Dillione JanetDirector
|
PurchaseCommon Stock | 52,083 | $0.48 | $24,999.84 |
DisclosureSEC source: 0001654954-17-011655 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,052 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:11 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 52,083 | $0.48 | $24,999.84 |
DisclosureSEC source: 0001654954-17-011652 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,083 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:15 UTC |
Lefkowitz Steven WDirector
|
PurchaseCommon Stock, $0.001 par value per share | 135,416 | $0.48 | $64,999.68 |
DisclosureSEC source: 0001654954-17-011656 · section16.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,379 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. F2 · ownership.direct: Includes 24,963 shares held by the reporting person for the benefit of his minor son. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:09 UTC |
Cook Robert W.Chief Financial Officer
|
PurchaseCommon Stock | 52,083 | $0.48 | $24,999.84 |
DisclosureSEC source: 0001654954-17-011650 · section16.xml · nonDerivative · entry 1 Cook Robert W. · CIK 0001235438 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,083 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:08 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
PurchaseCommon Stock | 20,833 | $0.48 | $9,999.84 |
DisclosureSEC source: 0001654954-17-011649 · section16.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,833 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 16:01 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 15,625 | $0.48 Strike: $0.00 | $7,500.00 |
DisclosureSEC source: 0001654954-17-010802 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,625 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for director's fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 06, 2017 Filed Dec 15, 2017 16:01 UTC |
Kaplan MyronDirector
|
GrantRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-17-011696 · section16.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of November 6, 2017, subject to continued service on the board. F1 · derivative.exercise_date: The restricted stock units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of November 6, 2017, subject to continued service on the board. F1 · derivative.expiration_date: The restricted stock units were granted on 11/6/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of November 6, 2017, subject to continued service on the board. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 20:03 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 36,207 | $0.42 | $15,025.91 |
DisclosureSEC source: 0001654954-17-007836 · section16.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,207 Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 20:01 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 50,000 | $0.42 | $21,000.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 5 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 07:43 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 80,000 | $0.40 | $31,840.00 |
DisclosureSEC source: 0001654954-17-007775 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.380 to $0.410. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 17, 2017 Filed Aug 22, 2017 20:01 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 150,000 | $0.41 | $61,500.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 4 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Read SEC document |
| August 16, 2017 Filed Aug 22, 2017 20:01 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 100,000 | $0.39 | $39,000.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Read SEC document |
| August 15, 2017 Filed Aug 22, 2017 20:01 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 50,000 | $0.37 | $18,500.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 16:02 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 50,000 | $0.35 | $17,400.00 |
DisclosureSEC source: 0001654954-17-007678 · section16.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.3344 to $0.36. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 14, 2017 Filed Aug 22, 2017 20:01 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 50,000 | $0.35 | $17,500.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| August 14, 2017 Filed Aug 24, 2017 07:42 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-17-007866 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,833 Underlying: Common Stock · 20,833 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 16:31 UTC |
Gelbfish Gary A.Director
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001654954-17-007011 · section16.xml · derivative · entry 3 Gelbfish Gary A. · CIK 0001488011 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock, $0.001 par value per share · 75,000 shares Expires 2027-08-03 F2 · derivative.exercise_date: These options vest as follows: 1/3 on August 3, 2017, an additional 1/3 on August 3, 2018, and the remaining 1/3 on August 3, 2019. Read SEC document |
| June 25, 2017 Filed Jun 27, 2017 20:04 UTC |
Khan MehmoodDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001654954-17-005931 · section16.xml · derivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-06-25 F1 · derivative.exercise_date: These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant. Read SEC document |
| June 25, 2017 Filed Jun 28, 2017 20:03 UTC |
Lefkowitz Steven WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001654954-17-005969 · section16.xml · derivative · entry 4 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-06-25 F3 · derivative.exercise_date: These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.